Microbiomes – Multimedia

A recent study from Monash University highlights the potential symbiotic relationship between bacteriophages, viruses that infect bacteria, and mammalian cells.

A new study in mice has found that changes to the gut microbiome during spaceflight may be associated with bone loss.

Speaking at The Landscape of Cancer Research 2022 online symposium, James Moon from the University of Michigan delivered his talk on next-generation STING agonists for immunotherapy against advanced cancer.

In this infographic, we explore some of the ways that next-generation sequencing (NGS) has changed our understanding of biology and medicine by detailing some of its most important applications.

Speaking at the online symposium, Innovations in Disease Modeling 2022, Dr. Donald E. Ingber, Founding Director of Wyss Institute for Biologically Inspired Engineering at Harvard University, presented his talk on novel human organ-on-a-chip technologies

Dr. Erika Ebbel Angle discusses why the gut microbiome is the most important organ you’ve probably never heard of.

In this bumper episode, the team review a series of studies from the last year that investigate Christmassy food. Could the future of Christmas dinner involve a cell culture roast, unnaturally smooth chocolate and fractal cauliflower?

In this episode, the team examine a new study that challenges the notion that gut microbes may play a causal role in autism spectrum disorder. Might a link once ascribed to signaling from the gut’s nervous system actually just be a consequence of restricted diet?

In this episode, the Technology Networks team review a pair of studies showing off the power of microbes. In one, they act as a conduit in an unlikely potential health benefit for a high-salt diet. In the other, they are revealed to play an important role in the breakdown of plastic in the environment.

A new study led by Scripps Research scientist Howard Hang, PhD, explains how and why a certain species of bacteria in the digestive tract significantly improves the tumor-fighting ability of approved cancer drugs known as checkpoint inhibitors.